Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors


Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Structure of the NAB2-STAT6 fusion.


  1. Mertens, F. et al. Semin. Oncol. 36, 312–323 (2009).

    Article  CAS  Google Scholar 

  2. Svaren, J. et al. Mol. Cell. Biol. 16, 3545–3553 (1996).

    Article  CAS  Google Scholar 

  3. Bhattacharyya, S. et al. PLoS ONE 4, e7620 (2009).

    Article  Google Scholar 

  4. Shimoyamada, H. et al. Am. J. Pathol. 177, 70–83 (2010).

    Article  CAS  Google Scholar 

  5. Abdulkadir, S.A. et al. Hum. Pathol. 32, 935–939 (2001).

    Article  CAS  Google Scholar 

  6. Pal, N.R., Aguan, K., Sharma, A. & Amari, S. BMC Bioinformatics 8, 5 (2007).

    Article  Google Scholar 

  7. Hebenstreit, D., Wirnsberger, G., Horejs-Hoeck, J. & Duschl, A. Cytokine Growth Factor Rev. 17, 173–188 (2006).

    Article  CAS  Google Scholar 

  8. Nelson, E.A., Sharma, S.V., Settleman, J. & Frank, D.A. Oncotarget. 2, 518–524 (2011).

    Article  Google Scholar 

  9. Merk, B.C., Owens, J.L., Lopes, M.B., Silva, C.M. & Hussaini, I.M. BMC Cancer 11, 184 (2011).

    Article  CAS  Google Scholar 

  10. He, H.J. et al. J. Biol. Chem. 281, 31369–31379 (2006).

    Article  CAS  Google Scholar 

  11. Imielinski, M. et al. Cell 150, 1107–1120 (2012).

    Article  CAS  Google Scholar 

  12. Hammerman, P.S. et al. Nature 489, 519–525 (2012).

    Article  CAS  Google Scholar 

  13. Barbieri, C.E. et al. Nat. Genet. 44, 685–689 (2012).

    Article  CAS  Google Scholar 

  14. Pugh, T.J. et al. Nature 488, 106–110 (2012).

    Article  CAS  Google Scholar 

  15. Banerji, S. et al. Nature 486, 405–409 (2012).

    Article  CAS  Google Scholar 

Download references


We are grateful to the individuals with SFT who contributed material for this study. We thank members of the Genomics Platform at the Broad Institute for their technical expertise and M. Abazeed and A. Dulak for critically reviewing the manuscript. This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA), a project funded by the Carlos Slim Health Institute in Mexico. This work was supported by a Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma (P50 CA140146) and a P01 grant (P01CA47179) to S. Singer (MSKCC). J.C. is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. A.M.C. is supported by a grant from the Kristen Ann Carr Foundation. M.M. is supported by generous donations from M.B. Zuckerman and Team Dragonfly of the Pan-Mass Challenge. Material was collected under institutional review board (IRB)-approved protocols at the Memorial Sloan-Kettering Cancer Center and the Oregon Health & Science University Biolibrary. All patients provided informed consent.

Author information

Authors and Affiliations



J.C. and M.M. conceived the project. J.C., A.M.C. and M.M. wrote the manuscript with input from all coauthors. J.C., A.M.C. and R.O. performed experiments. J.C. and M.R. performed computational analyses. A.M. contributed an unpublished algorithm to the analysis. J.C., A.M.C., M.R., S.R.W., R.O., D.A.F. and M.M. analyzed the results. A.M.C. and M.C.H. contributed samples. L.A. and D.A. facilitated the transfer, sequencing and analysis of samples.

Corresponding author

Correspondence to Matthew Meyerson.

Ethics declarations

Competing interests

M.M. is a paid consultant for and equity holder in Foundation Medicine, a genomics-based oncology diagnostics company, and is a paid consultant for Novartis. M.C.H. is a paid consultant for and equity holder in Molecular MD, a molecular diagnostics company, and is a paid consultant for Novartis.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Figures 1–4 and Supplementary Tables 1–5 (PDF 2583 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chmielecki, J., Crago, A., Rosenberg, M. et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45, 131–132 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer